On August 10, U.S. Food and Drug Administration (FDA) approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), which is a combined hormonal contraceptive for women and is the first vaginal ring contraceptive that can be used for an entire year.
Read more via U.S. Food & Drug Administration.
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
